STOCK TITAN

Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogenetics, Microsurgery, and Medical Device Manufacturing

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

Coherent (NYSE:COHR) has introduced Osprey, a new femtosecond laser designed for optogenetics, microsurgery, and medical device manufacturing. The laser delivers pulse energies up to 5 µJ and sub-350 fs pulse widths with exceptional beam quality and pointing stability.

Key features include industrial-grade reliability, simplified integration, and high performance enabled by ultrafast fiber laser technology. The system operates on a standard 24V DC supply with power draw under 150W, featuring integrated AOM and wide dispersion pre-compensation for complex optical paths.

Qualification units are available now, with volume production starting January 2026. The product complements Coherent's existing ultrafast portfolio, including Monaco and Axon series.

Loading...
Loading translation...

Positive

  • Advanced fiber-based architecture delivers superior performance and stability
  • Low power consumption under 150W with standard 24V DC supply compatibility
  • Expands product portfolio for growing medical and life sciences markets
  • Designed for industrial-grade reliability and simplified integration

Negative

  • Volume production not starting until January 2026
  • -

News Market Reaction

+0.40%
1 alert
+0.40% News Effect

On the day this news was published, COHR gained 0.40%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAXONBURG, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today introduces Osprey, its newest femtosecond laser designed for demanding applications in optogenetics, microsurgery, and medical device manufacturing. Engineered for precision and reliability, Osprey delivers pulse energies of up to 5 µJ and sub-350 fs pulse widths. Osprey delivers exceptional beam quality and pointing stability, all in a compact form factor and with industry-leading power efficiency. These features make it ideal for integration into precision microscopes and advanced medical tools.

The introduction of Osprey comes at a pivotal moment as femtosecond lasers move beyond research settings into clinical and industrial environments. In these applications, repeatability, reliability, beam quality, and cost efficiency have become more critical than peak power. Osprey addresses these evolving needs with industrial-grade reliability, simplified integration, and high performance enabled by the latest ultrafast fiber laser technology.

“Osprey combines decades of ultrafast laser expertise with a fiber-based architecture that delivers best-in-class performance and reliability,” said Dr. Chris Dorman, Executive Vice President, Lasers Business Group at Coherent. “We designed Osprey to deliver clean, stable, high-quality femtosecond pulses with minimal power draw and maximum system stability – a game-changer for medical and life sciences applications.”

Osprey’s fiber-based architecture delivers significant performance advantages over competing systems. Leveraging deep expertise in ultrafast fiber technology, the laser generates high-quality pulses using specifically designed solid-core fibers that are virtually free of aging effects while maintaining superior ruggedness and pointing stability. With a power draw under 150 W, Osprey runs on a standard 24 V DC supply. Integrated AOM and wide dispersion pre-compensation enable smooth operation across complex optical paths, critical for wide field-of-view imaging and fiber delivery systems.

Osprey complements the existing ultrafast portfolio from Coherent for two-photon optogenetics, which include the Monaco and the Axon series, optimized for two-photon calcium imaging. Together, this comprehensive lineup provides researchers and engineers with a complete toolkit for advanced bioimaging and microsurgery workflows.

Qualification units of Osprey are available, with volume production scheduled for January 2026. Coherent will showcase the Osprey at LASER World of Photonics Munich 2025.

About Coherent

Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at coherent.com.

Media Contact:
innovations@coherent.com 


FAQ

What are the key specifications of Coherent's new Osprey femtosecond laser?

The Osprey laser delivers pulse energies up to 5 µJ, sub-350 fs pulse widths, exceptional beam quality, and pointing stability, all in a compact form factor with power draw under 150W.

When will Coherent (NYSE:COHR) begin volume production of the Osprey laser?

Coherent will begin volume production of the Osprey laser in January 2026, though qualification units are currently available.

What applications is the Coherent Osprey laser designed for?

The Osprey laser is specifically designed for optogenetics, microsurgery, and medical device manufacturing applications, particularly in clinical and industrial environments.

How does the Osprey laser complement Coherent's existing product line?

Osprey complements Coherent's existing ultrafast portfolio, including the Monaco and Axon series, which are optimized for two-photon calcium imaging and optogenetics applications.

What power supply does the Coherent Osprey laser require?

The Osprey laser operates on a standard 24V DC supply with a power draw of less than 150W.
Coherent Corp

NYSE:COHR

COHR Rankings

COHR Latest News

COHR Latest SEC Filings

COHR Stock Data

33.92B
186.44M
1.22%
96.1%
5.21%
Scientific & Technical Instruments
Optical Instruments & Lenses
Link
United States
SAXONBURG